Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (2)
Type
Type
Guidance (23)
NICE advice (1)
Guidance programme
Guidance programme
Clinical guidelines (6)
COVID-19 rapid guidelines (1)
Health technology evaluations (4)
NICE guidelines (7)
Technology appraisal guidance (12)
Advice programme
Advice programme
Evidence summaries (1)
Apply filters
Showing 1 to 24 of 24
Sort by
Date
Title
Apply sorting
Last updated date between 1/3/2024 and 31/3/2024
Remove Last updated date between 1/3/2024 and 31/3/2024 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Sebelipase alfa for treating lysosomal acid lipase deficiency that is not Wolman disease (terminated appraisal)
TA961
28 March 2024
28 March 2024
Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy
TA962
28 March 2024
28 March 2024
Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal)
TA965
28 March 2024
28 March 2024
Ritlecitinib for treating severe alopecia areata in people 12 years and over
TA958
27 March 2024
27 March 2024
Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis
TA959
27 March 2024
27 March 2024
Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal)
TA960
27 March 2024
27 March 2024
Desflurane for maintenance of anaesthesia
ES41
26 March 2024
26 March 2024
Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment
HTE17
25 March 2024
25 March 2024
Ovarian cancer: identifying and managing familial and genetic risk
NG241
21 March 2024
21 March 2024
Momelotinib for treating myelofibrosis-related splenomegaly or symptoms
TA957
20 March 2024
20 March 2024
Suspected sepsis: recognition, diagnosis and early management
NG51
13 July 2016
19 March 2024
Neonatal infection: antibiotics for prevention and treatment
NG195
20 April 2021
19 March 2024
Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management
NG240
19 March 2024
19 March 2024
ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment
HTE5
28 March 2023
14 March 2024
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
TA878
29 March 2023
13 March 2024
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema
TA953
13 March 2024
13 March 2024
Dupilumab for treating moderate to severe prurigo nodularis
TA955
13 March 2024
13 March 2024
COVID-19 rapid guideline: managing COVID-19
NG191
23 March 2021
13 March 2024
Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over
TA956
11 March 2024
11 March 2024
Lung cancer: diagnosis and management
NG122
28 March 2019
8 March 2024
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
TA954
6 March 2024
6 March 2024
Vitamin B12 deficiency in over 16s: diagnosis and management
NG239
6 March 2024
6 March 2024
Digital technologies for delivering multidisciplinary weight-management services: early value assessment
HTE14
26 October 2023
6 March 2024
Digital technologies for managing non-specific low back pain: early value assessment
HTE16
5 March 2024
5 March 2024
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top